(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in mutation detection kits for genome editing include addressing rising genetic disorders with precise diagnostics, leveraging innovations like ultrasensitive assays and digital technologies, and expanding in fast-growing regions like Asia-Pacific. Collaboration and overcoming trade challenges could further enhance growth.

Dublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Mutation Detection Kits in Genome Editing Market Report 2025" has been added to ResearchAndMarkets's offering.
The mutation detection kits in the genome editing market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.14 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historical period can be attributed to increasing research on genetic disorders, rising government funding for genomics, expanding academic and clinical research collaborations, greater availability of advanced molecular biology tools, and growing investments from biotechnology companies.
The mutation detection kits in the genome editing market size are expected to see rapid growth in the next few years. It will grow to $1.86 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth during the forecast period can be attributed to increasing adoption of autonomous mobile robots (AMRs), greater focus on supply chain visibility, rising investment in digital twin technologies, growing demand for real-time asset tracking, and expanding use of industrial automation.

Key trends expected in the forecast period include advancements in real-time location systems (RTLS), innovations in AI-powered asset tracking, integration of RFID with IoT platforms, progress in ultra-wideband (UWB) technology, and incorporation of digital twin solutions into industrial automation.

The increasing prevalence of genetic disorders is expected to drive the growth of mutation detection kits in the genome editing market in the coming years. Genetic disorders are conditions caused by abnormalities in an individual's DNA, either inherited from parents or resulting from new genetic mutations. The reported rise in genetic disorders is fueled by greater awareness and advances in diagnostic technologies, which allow for earlier and more accurate identification of these conditions. Mutation detection kits for genome editing help address genetic disorders by precisely identifying disease-causing gene mutations, supporting targeted research and the development of effective therapeutic interventions. For example, in May 2024, the National Health Service, a UK-based government department, reported that approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. As a result, the growing prevalence of genetic disorders is boosting the demand for mutation detection kits in the genome editing market.
Key players in the mutation detection kits market are focusing on developing advanced products, such as ultrasensitive multiplexed assays, to improve accuracy, speed, and sensitivity in detecting genetic mutations. Ultrasensitive multiplexed assays are sophisticated diagnostic tests capable of simultaneously detecting and quantifying multiple genetic mutations at very low levels, enabling faster, more accurate, and comprehensive mutation analysis for improved disease diagnosis and monitoring. For instance, in April 2024, Bio-Rad Laboratories Inc., a US-based research company, launched the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay designed for breast cancer mutation detection. This kit allows simultaneous identification and precise quantification of seven ESR1 mutations with an analytical sensitivity down to 0.01% variant allele fraction, supporting analysis of both plasma and tissue samples. Such innovations reflect the industry's focus on enhancing diagnostic accuracy and enabling personalized treatment strategies.
In March 2025, ERS Genomics Limited, an Ireland-based biotechnology company, partnered with Jumpcode Genomics Inc. to advance next-generation sequencing capabilities. Through this partnership, Jumpcode Genomics Inc. plans to leverage ERS Genomics Limited's CRISPR/Cas9 patent portfolio to improve its next-generation sequencing technologies, achieving higher sensitivity, enhanced efficiency, and expanded applications in areas including basic research, infectious disease detection, molecular diagnostics, and oncology. Jumpcode Genomics Inc., based in the US, provides advanced tools for mutation detection and genome editing.
Major players in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, Cell Signaling Technology Inc., BioVision Inc., Creative Biogene Corporation.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2025 - 2029
Estimated Market Value (USD) in 2025	$1.14 Billion
Forecasted Market Value (USD) by 2029	$1.86 Billion
Compound Annual Growth Rate	13.1%
Regions Covered	Global

Key Topics Covered:

Markets Covered:

• By Product Type: Reagents; Kits; Software Solutions
• By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR); Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs); Zinc Finger Nucleases (ZFN); Other Technologies
• By Application: Research; Clinical Diagnostics; Drug Development; Other Applications
• By End Use: Academic Institutions; Hospitals and Diagnostic Centers; Biotechnology Companies

Subsegments:

• By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases; Nucleases; Buffers and Enzymes; Fluorescent Dyes and Probes; Primers and Oligonucleotides
• By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits; Next-Generation Sequencing-Based Mutation Analysis Kits; Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits; Gel Electrophoresis-Based Detection Kits
• By Software Solutions: Mutation Analysis and Visualization Tools; Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software; Genomic Alignment and Annotation Software; Data Interpretation Platforms for Next-Generation Sequencing; Cloud-Based Bioinformatics Platforms

Mutation Detection Kits in Genome Editing Market Regional and Country Analysis

Mutation Detection Kits in Genome Editing Market Competitive Landscape and Company Profiles

• F. Hoffmann-La Roche Ltd - Overview, Products and Services, Strategy and Financial Analysis
• Merck KGaA - Overview, Products and Services, Strategy and Financial Analysis
• Thermo Fisher Scientific Inc. - Overview, Products and Services, Strategy and Financial Analysis
• QIAGEN N.V. - Overview, Products and Services, Strategy and Financial Analysis
• Eurofins Scientific SE - Overview, Products and Services, Strategy and Financial Analysis

Mutation Detection Kits in Genome Editing Market Other Major and Innovative Companies

• Agilent Technologies Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Integrated DNA Technologies Inc.
• GenScript Biotech Corporation
• Takara Bio Inc.
• Promega Corporation
• Analytik Jena AG
• Twist Bioscience Corporation
• New England Biolabs Inc.
• Applied Biological Materials Inc.
• Synthego Corporation
• Cell Signaling Technology Inc.
• BioVision Inc.
• Creative Biogene Corporation

Global Mutation Detection Kits in Genome Editing Market Competitive Benchmarking and Dashboard
Key Mergers and Acquisitions in the Mutation Detection Kits in Genome Editing Market
Recent Developments in the Mutation Detection Kits in Genome Editing Market
Mutation Detection Kits in Genome Editing Market High Potential Countries, Segments and Strategies

• Countries Offering Most New Opportunities
• Segments Offering Most New Opportunities
• Growth Strategies

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Mutation Detection Kits in Genome Editing Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14102025004107003653ID1110193488